cb-010,fludarabine,cyclophosphamide
Caribou Biosciences
['car-t', 'ribo']
$crbu caribou biosciences reports positive additional data from cb-010 allogeneic car-t cell therapy phase 1 antler trial at the european hematology association (eha) 2022 hybrid congress 45 seconds delayed.
Democratizing insights.

Not investment advice.